TPT1P14

Across TCGA pan-cancer cohorts, TPT1P14 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated TPT1P14 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher TPT1P14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TPT1P14 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SKCM show a favorable association.

BRCA, STAD, and LUAD are the cancer types where TPT1P14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
STAD	DFS	Tertile	III,IV	0.259	0.577	.006	32	view →
LUAD	OS	Tertile	All	0.157	0.489	<.001	29	view →
READ	OS	Median	III,IV	0.501	1.000	.012	29	view →
LUSC	OS	Quartile	II,III,IV	0.526	0.304	.006	21	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
ACC	DFS	Tertile	II,III,IV	0.260	0.653	.006	17	view →
PAAD	OS	Tertile	All	0.348	0.499	.037	11	view →
SKCM	OS	Tertile	III,IV	0.550	0.296	.007	7	view →
THYM	DFS	Quartile	II,III,IV	0.782	0.967	.021	5	view →
HNSC	OS	Quartile	IV	0.555	0.340	.031	5	view →
OV	OS	Quartile	All	0.816	0.890	.027	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

TPT1P14–BRCA (DFS)

Open the BRCA breakdown →